Role of heparan sulfate proteoglycans in the uptake and degradation of tissue factor pathway inhibitor-coagulation factor Xa complexes

被引:57
作者
Ho, GY
Broze, GJ
Schwartz, AL
机构
[1] WASHINGTON UNIV,SCH MED,DEPT BIOL MOL,ST LOUIS,MO 63110
[2] WASHINGTON UNIV,SCH MED,DEPT PHARMACOL,ST LOUIS,MO 63110
[3] JEWISH HOSP ST LOUIS,DIV HEMATOL,ST LOUIS,MO 63110
关键词
D O I
10.1074/jbc.272.27.16838
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tissue factor pathway inhibitor (TFPI) is a potent inhibitor of blood coagulation factor Xa. (fXa) and factor VIIa. We have recently shown that fXa binding stimulates the uptake and degradation of cell surface-bound I-125-TFPI (He, G., Toomey, J. pg., Broze, G. J., Jr., and Schmartz, A. L. (1996) J. Biol. Chem. 271, 9497-9502). in the present study ave examined the role of cell surface glycosaminoglycans (GAGs) in this process, Removal of cell surface GAG chains by treatment of Cells with heparinase or heparitinase but not chondroitinase markedly reduced fXa-stimulated I-125-TFPI uptake and degradation, Inhibition of GAG sulfation by growth of cells in chlorate-containing medium similarly decreased fXa-stimulated I-125-TFPI degradation. These results suggest that heparan sulfate proteoglycans (HSPGs) are required fur the uptake and degradation of I-125-TFPI.fXa complexes. Chemical cross-linking/immunoprecipitation analyses revealed that I-125-TFPI was directly associated with HSPGs on the cell surface and that fXa binding increased the amount of I-125-TFPI bound, Of the several cell lines evaluated, bend endothelial cells demonstrated the greatest fXa stimulation of I-125-TFPI uptake and degradation, Cross-linking/immunoprecipitation analyses on bend cells also revealed that HSPGs were specifically associated with TFPI and fXa. These data suggest that HSPGs may directly act as the uptake and degradation receptor for TFPI.fXa complexes.
引用
收藏
页码:16838 / 16844
页数:7
相关论文
共 39 条
[1]   BIOLOGY OF THE SYNDECANS - A FAMILY OF TRANSMEMBRANE HEPARAN-SULFATE PROTEOGLYCANS [J].
BERNFIELD, M ;
KOKENYESI, R ;
KATO, M ;
HINKES, MT ;
SPRING, J ;
GALLO, RL ;
LOSE, EJ .
ANNUAL REVIEW OF CELL BIOLOGY, 1992, 8 :365-393
[2]  
BROZE GJ, 1994, BLOOD COAGUL FIBRIN, V5, P551
[3]  
BROZE GJ, 1988, BLOOD, V71, P335
[4]   REGULATION OF COAGULATION BY A MULTIVALENT KUNITZ-TYPE INHIBITOR [J].
BROZE, GJ ;
GIRARD, TJ ;
NOVOTNY, WF .
BIOCHEMISTRY, 1990, 29 (33) :7539-7546
[5]  
BU G, 1994, CELL BIOL LAB HDB, P199
[6]  
BU GJ, 1992, J BIOL CHEM, V267, P15595
[7]  
BU GJ, 1993, J BIOL CHEM, V268, P13002
[8]   ANTI-CLOTTING ACTIVITY OF ENDOTHELIAL CELL-CULTURES AND HEPARAN-SULFATE PROTEOGLYCANS [J].
COLBURN, P ;
BUONASSISI, V .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1982, 104 (01) :220-227
[9]   MOLECULAR-CLONING OF A PHOSPHATIDYLINOSITOL-ANCHORED MEMBRANE HEPARAN-SULFATE PROTEOGLYCAN FROM HUMAN LUNG FIBROBLASTS [J].
DAVID, G ;
LORIES, V ;
DECOCK, B ;
MARYNEN, P ;
CASSIMAN, JJ ;
VANDENBERGHE, H .
JOURNAL OF CELL BIOLOGY, 1990, 111 (06) :3165-3176
[10]   Genetic analysis of proteoglycan structure, function and metabolism [J].
Esko, Jeffrey D. .
CURRENT OPINION IN CELL BIOLOGY, 1991, 3 (05) :805-816